Sugemalimab with chemotherapy for untreated advanced non-small-cell lung cancer [ID6758]

Status:

In progress

Technology type:

Medicine

Decision:

Prioritised

Rationale:

Sugemalimab with chemotherapy for untreated advanced non-small-cell lung cancer [ID6758]

Process:

STA Standard

ID number:

6758

Timeline

Key events during the development of the guidance:

For further information on our processes and methods, please see our CHTE processes and methods manual